IQVIA Holdings (LTS:0JDM) Interest Expense : $-697 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. IQVIA Holdings's interest expense for the three months ended in Mar. 2024 was $ -166 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-697 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. IQVIA Holdings's Operating Income for the three months ended in Mar. 2024 was $ 521 Mil. IQVIA Holdings's Interest Expense for the three months ended in Mar. 2024 was $ -166 Mil. IQVIA Holdings's Interest Coverage for the quarter that ended in Mar. 2024 was 3.14. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

IQVIA Holdings Interest Expense Historical Data

The historical data trend for IQVIA Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Interest Expense Chart

IQVIA Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-447.00

-416.00

-375.00

-416.00

-672.00

IQVIA Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-141.00	-169.00	-181.00	-181.00	-166.00

IQVIA Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-697 Mil.

IQVIA Holdings (LTS:0JDM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

IQVIA Holdings's Interest Expense for the three months ended in Mar. 2024 was $-166 Mil. Its Operating Income for the three months ended in Mar. 2024 was $521 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $13,023 Mil.

IQVIA Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	521	/	-166
	=	3.14

The higher the ratio, the stronger the company's financial strength is.

IQVIA Holdings (LTS:0JDM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico QTS:Germany I1QV34:Brazil

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (LTS:0JDM) Headlines

No Headlines